Is rituximab one for all ages and each sex?

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


In this issue of Blood, Pfreundschuh et al report that young males treated with rituximab-based immunochemotherapy in contrast to elderly males benefit as much as females from rituximab immunochemotherapy and patients with more rapid rituximab clearance have reduced therapeutic benefit.

Original languageEnglish (US)
Pages (from-to)602-603
Number of pages2
Issue number5
StatePublished - Jan 30 2014

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology


Dive into the research topics of 'Is rituximab one for all ages and each sex?'. Together they form a unique fingerprint.

Cite this